Rapid Dose Therapeutics Extends Nicotine Partnership and Expands into Saudi Arabian Market

Rapid Dose Therapeutics has extended its strategic partnership with a global nicotine manufacturer and launched a commercialization initiative for the Saudi Arabian market. The agreement continues the development and distribution of the company’s proprietary drug delivery technology, while the expansion into Saudi Arabia marks the next phase of the firm’s international growth strategy.

The extended collaboration focuses on the integration of Rapid Dose Therapeutics’ oral thin-film delivery system with the partner’s nicotine products. Under the terms of the agreement, the two companies will continue to refine the product formulation and scale manufacturing processes to meet international demand. Simultaneously, the company has begun regulatory and logistical preparations to introduce its products to the Saudi Arabian market. This move follows the company’s broader efforts to establish a footprint in the Middle East, where it intends to leverage its existing supply chain to distribute its nicotine-delivery solutions to local consumers.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: July 7, 2026

Author

GOAI